DK1322654T3 - Platinkomplekser som antitumormidler - Google Patents

Platinkomplekser som antitumormidler

Info

Publication number
DK1322654T3
DK1322654T3 DK01975671T DK01975671T DK1322654T3 DK 1322654 T3 DK1322654 T3 DK 1322654T3 DK 01975671 T DK01975671 T DK 01975671T DK 01975671 T DK01975671 T DK 01975671T DK 1322654 T3 DK1322654 T3 DK 1322654T3
Authority
DK
Denmark
Prior art keywords
tumor agents
platinum complexes
complexes
platinum
tumor
Prior art date
Application number
DK01975671T
Other languages
English (en)
Inventor
Christen M Giandomenico
Ernest S Y Wong
Original Assignee
Anormed Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Anormed Inc filed Critical Anormed Inc
Application granted granted Critical
Publication of DK1322654T3 publication Critical patent/DK1322654T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F15/00—Compounds containing elements of Groups 8, 9, 10 or 18 of the Periodic Table
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F15/00—Compounds containing elements of Groups 8, 9, 10 or 18 of the Periodic Table
    • C07F15/0006—Compounds containing elements of Groups 8, 9, 10 or 18 of the Periodic Table compounds of the platinum group
    • C07F15/0086—Platinum compounds
    • C07F15/0093—Platinum compounds without a metal-carbon linkage
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
DK01975671T 2000-10-04 2001-10-02 Platinkomplekser som antitumormidler DK1322654T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US09/678,595 US6894049B1 (en) 2000-10-04 2000-10-04 Platinum complexes as antitumor agents
PCT/US2001/030838 WO2002028871A1 (en) 2000-10-04 2001-10-02 Platinum complexes as antitumor agents

Publications (1)

Publication Number Publication Date
DK1322654T3 true DK1322654T3 (da) 2009-04-14

Family

ID=24723449

Family Applications (1)

Application Number Title Priority Date Filing Date
DK01975671T DK1322654T3 (da) 2000-10-04 2001-10-02 Platinkomplekser som antitumormidler

Country Status (13)

Country Link
US (1) US6894049B1 (da)
EP (1) EP1322654B1 (da)
JP (1) JP2004510778A (da)
KR (1) KR100864596B1 (da)
AR (1) AR032185A1 (da)
AT (1) ATE417855T1 (da)
AU (1) AU2001294969A1 (da)
DE (1) DE60137061D1 (da)
DK (1) DK1322654T3 (da)
ES (1) ES2319258T3 (da)
PT (1) PT1322654E (da)
SI (1) SI1322654T1 (da)
WO (1) WO2002028871A1 (da)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0011903D0 (en) * 2000-05-18 2000-07-05 Astrazeneca Ab Combination chemotherapy
RS50605B (sr) 2004-02-18 2010-05-07 Gpc Biotech Ag. Satraplatina za tretiranje rezistentnih i otpornih tumora
CZ296459B6 (cs) * 2004-09-14 2006-03-15 Pliva-Lachema A. S. Perorální farmaceutická kompozice pro cílený transport komplexu platiny do kolorektální oblasti, zpusob její prípravy a tato kompozice pro pouzití jako lécivo
CA2612709C (en) * 2005-06-30 2013-10-15 Bionumerik Pharmaceuticals, Inc. Monoimine ligand platinum analogs
MX2007015852A (es) * 2005-06-30 2008-02-22 Bionumerik Pharmaceuticals Inc Analogos de platino con ligandos de monoazol.
WO2007021852A2 (en) * 2005-08-11 2007-02-22 Virginia Commonwealth University Transplatinum complexes with n2o2 donor sets as cytotoxic and antitumor agents
US8168661B2 (en) * 2006-11-06 2012-05-01 Poniard Pharmaceuticals, Inc. Use of picoplatin to treat colorectal cancer
US8168662B1 (en) 2006-11-06 2012-05-01 Poniard Pharmaceuticals, Inc. Use of picoplatin to treat colorectal cancer
US8173686B2 (en) 2006-11-06 2012-05-08 Poniard Pharmaceuticals, Inc. Use of picoplatin to treat colorectal cancer
US8178564B2 (en) * 2006-11-06 2012-05-15 Poniard Pharmaceuticals, Inc. Use of picoplatin to treat colorectal cancer
JP2010518088A (ja) * 2007-02-09 2010-05-27 ポニアード ファーマシューティカルズ， インコーポレイテッド カプセル化されたピコプラチン
US20110033528A1 (en) * 2009-08-05 2011-02-10 Poniard Pharmaceuticals, Inc. Stabilized picoplatin oral dosage form
US8697350B2 (en) * 2007-06-04 2014-04-15 Diagnoplex Biomarker combinations for colorectal cancer
TW200916094A (en) * 2007-06-27 2009-04-16 Poniard Pharmaceuticals Inc Stabilized picoplatin dosage form
US20100260832A1 (en) * 2007-06-27 2010-10-14 Poniard Pharmaceuticals, Inc. Combination therapy for ovarian cancer
WO2009011861A1 (en) * 2007-07-16 2009-01-22 Poniard Pharmaceuticals, Inc. Oral formulations for picoplatin
AU2009210654A1 (en) * 2008-02-08 2009-08-13 Poniard Pharmaceuticals, Inc. Use of picoplatin and bevacizumab to treat colorectal cancer
CZ306396B6 (cs) * 2014-12-16 2017-01-04 Vuab Pharma A.S. Rozpustný platnatý komplex s pyridinkarboxamidinovým ligandem a způsob jeho přípravy
WO2022217255A1 (en) * 2021-04-07 2022-10-13 Klotho Therapeutics, Inc. Novel antitumor compounds and related methods of manufacture and use

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4329299A (en) 1979-08-23 1982-05-11 Johnson, Matthey & Co., Limited Composition of matter containing platinum
US4533502A (en) 1983-02-22 1985-08-06 Rochon Fernande D Platinum (II) compounds and their preparation
ATE63919T1 (de) 1984-06-27 1991-06-15 Johnson Matthey Plc Platinkoordinationsverbindungen.
US4921963A (en) * 1987-04-13 1990-05-01 British Columbia Cancer Foundation Platinum complexes with one radiosensitizing ligand
US5244919A (en) 1988-02-02 1993-09-14 Johnson Matthey, Inc. Pt(IV) complexes as anti-tumor agents
GB9105037D0 (en) 1991-03-09 1991-04-24 Johnson Matthey Plc Improvements in chemical compounds
US5624919A (en) * 1993-09-14 1997-04-29 The University Of Vermont And State Agricultural College Trans platinum (IV) complexes
GB9502799D0 (en) 1995-02-14 1995-04-05 Johnson Matthey Plc Improvements in platinum complexes
US5547982A (en) 1995-02-27 1996-08-20 Johnson Matthey, Inc. Anti-tumor platinum complexes
JP2004500321A (ja) 1999-03-19 2004-01-08 アノーメッド　インコーポレイティド 金属錯体を含む薬学的組成物
US6518428B1 (en) 1999-04-13 2003-02-11 Anormed, Inc. Process for preparing amine platinum complexes

Also Published As

Publication number Publication date
JP2004510778A (ja) 2004-04-08
KR20030059174A (ko) 2003-07-07
EP1322654B1 (en) 2008-12-17
WO2002028871A1 (en) 2002-04-11
EP1322654A1 (en) 2003-07-02
SI1322654T1 (sl) 2009-06-30
AU2001294969A1 (en) 2002-04-15
DE60137061D1 (de) 2009-01-29
US6894049B1 (en) 2005-05-17
KR100864596B1 (ko) 2008-10-22
ES2319258T3 (es) 2009-05-06
PT1322654E (pt) 2009-03-20
AR032185A1 (es) 2003-10-29
ATE417855T1 (de) 2009-01-15

Similar Documents

Publication Publication Date Title
NO20032531D0 (no) Tetralon-derivater som antitumormidler
DE60209377D1 (de) Alken-platin-silyl komplexe
NO20026195D0 (no) Substituerte-triazolopyrimidiner som anticancer midler
NO20031977D0 (no) 1-aryl- eller 1-alkylsulfonyl-heterocyklylbenzazoler som 5- hydroksytryptamin-6-ligander
DK1414440T3 (da) N-phenylpyrrolguanidinderivater som melanocortinreceptorligander
NO20015477L (no) 4,5,6,7-tetrahydroindazolderivater som antitumormidler
DK1355904T3 (da) Heterocyclindazol- og -azaindazolforbindelser som 5-hydroxytryptamin-6-ligander
NO20042279L (no) Kinazolinderivater som antitumormidler
NO20042288L (no) Kinazolinderivater som antitumormidler
NO20014759L (no) C(7)-estersubstituerte taxaner som antitumormidler
DK1322654T3 (da) Platinkomplekser som antitumormidler
ATE391531T1 (de) Schweisshemmende mittel
ATE288437T1 (de) Tetrahydro-heterocycloazepinyl-pyrimidin-deriva e
DK1353904T3 (da) 1-Aryl- eller 1-alkylsulfonylbenzazolderivater som 5-hydroxytryptamin-6-ligander
DK1456206T3 (da) Azaindolylalkylaminderivater som 5-hydroxytryptamin-6-ligander
DE60109409D1 (de) Neigungsverstellmechanismus
ATE327232T1 (de) Heterozyklylalkylindole oder -azaindole als 5- hydroxytryptamine-6 liganden
DK1455779T3 (da) Indolylalkylaminderivater som 5-hydroxytryptamin-6-ligander
DK1347974T3 (da) Aminotriazolopyridinderivater som adenosinreceptorligander
NO20014753L (no) C(10)-karbonatsubstituerte taxaner som antitumormidler
DE50204799D1 (de) Rückenlehne
NO20031239L (no) 1-amino-alkylsykloheksaner som trypanocidale midler
DK1283319T3 (da) Skillevæg
ITMI20011758A0 (it) Ligandi
DK1177185T3 (da) 4,5,6,7-tetrahydroindazolderivater som antitumormidler